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Structural and kinetic analysis of Escherichia coli GDP-mannose
4,6 dehydratase provides insights into the enzyme’s catalytic
mechanism and regulation by GDP-fucose
John R Somoza†, Saurabh Menon†, Holly Schmidt, Diane Joseph-McCarthy,
Andréa Dessen, Mark L Stahl, William S Somers and Francis X Sullivan*
Background: GDP-mannose 4,6 dehydratase (GMD) catalyzes the conversion
of GDP-(D)-mannose to GDP-4-keto, 6-deoxy-(D)-mannose. This is the first and
regulatory step in the de novo biosynthesis of GDP-(L)-fucose. Fucose forms
part of a number of glycoconjugates, including the ABO blood groups and the
selectin ligand sialyl Lewis X. Defects in GDP-fucose metabolism have been
linked to leukocyte adhesion deficiency type II (LADII).
Results: The structure of the GDP-mannose 4,6 dehydratase apo enzyme has
been determined and refined using data to 2.3 Å resolution. GMD is a
homodimeric protein with each monomer composed of two domains. The larger
N-terminal domain binds the NADP(H) cofactor in a classical Rossmann fold
and the C-terminal domain harbors the sugar-nucleotide binding site. We have
determined the GMD dissociation constants for NADP, NADPH and
GDP-mannose. Each GMD monomer binds one cofactor and one substrate
molecule, suggesting that both subunits are catalytically competent.
GDP-fucose acts as a competitive inhibitor, suggesting that it binds to the
same site as GDP-mannose, providing a mechanism for the feedback inhibition
of fucose biosynthesis.
Conclusions: The X-ray structure of GMD reveals that it is a member of the
short-chain dehydrogenase/reductase (SDR) family of proteins. We have
modeled the binding of NADP and GDP-mannose to the enzyme and mutated
four of the active-site residues to determine their function. The combined
modeling and mutagenesis data suggests that at position 133 threonine
substitutes serine as part of the serine–tyrosine–lysine catalytic triad common
to the SDR family and Glu135 functions as an active-site base.
Introduction
Fucose is distributed widely in the glycoconjugates of
species ranging from bacteria to humans. This sugar is
incorporated into glycoconjugates by specific fucosyltrans-
ferases that use GDP-fucose as a fucose donor. In bacteria,
fucose is found as part of the polysaccharides of the cell
wall and has been shown to play roles in pathogenicity [1]
and nodulation [2]. Additionally, in the human pathogen
Helicobacter pylori, biosynthesis of GDP-fucose is up-regu-
lated in response to an acidic environment and appears to
protect the bacteria from the challenges of acidic condi-
tions such as those found in the gut [3]. In mammals, the
biosynthesis of GDP-fucose is developmentally regulated
in rat [4] and is known to be important in embryonic devel-
opment in the mouse as part of the murine embryonic
antigen, SSEA [5]. In humans, fucose is distributed widely
in many glycoconjugates, and perhaps the best known
example is that of the human blood group antigens. More
recently, fucose has been shown to comprise part of the
epitope recognized by the selectin family of cell adhesion
molecules and, therefore, to play a role in immune func-
tion, inflammation, and metastasis [6,7]. 
In all species examined, the primary biosynthetic route to
GDP-fucose is from GDP-mannose [8]. This transforma-
tion is accomplished by two enzymes, GDP-mannose 4,6
dehydratase (GMD) and GDP-fucose synthetase (GFS)
[9–12]. In Escherichia coli, the gene for GMD, gmd, lies
immediately upstream of fcl, the gene encoding GFS [13].
Together these two enzymes convert GDP-mannose to
GDP-fucose in a three step reaction (Figure 1). The first
step of this reaction, catalyzed by GMD, involves the oxi-
dation of the C4 position of the mannose ring to a keto
functionality followed by the reduction of the C6 carbon
to a methyl group. This concerted oxidation and reduction
involves an intramolecular hydride transfer from the C4 to
the C6 on the mannose ring by a tightly bound NADP
cofactor, which becomes transiently reduced during the
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course of the reaction [14]. The product of the GMD-cat-
alyzed reaction, GDP-4-keto, 6-deoxy mannose, is first
epimerized at the C3 and C5 positions and then reduced
in an NADPH-dependent reaction by GFS to yield GDP-
L-fucose [9,10,15]. GMD has been proposed to be regu-
lated by feedback inhibition by GDP-fucose, and both the
human and bacterial enzymes are inhibited by the even-
tual end product of the biosynthetic pathway [9,16,17]. 
Defects in GMD activity have been identified in several
species and provide insight into the diverse roles that
fucose plays in biology. In plants, defects in gmd effect
shoot development in Arabidopsis [18]. In humans, defects
in the reaction catalyzed by GMD have been linked to the
immune disorder leukocyte adhesion deficiency type II
(LADII) [19,20]. These patients fail to fucosylate their
glycoconjugate and as a consequence show the rare
Bombay blood group. They also fail to synthesize fucosy-
lated ligands for selectins, are deficient in selectin-medi-
ated cell adhesion, and have defects in leukocyte
extravasation. Cloning of the genes for GMD and GFS
from LADII patients has failed to reveal a defect in the
sequence of either of the genes or in their message levels
[21] (XJ Chang, R Kumar and FXS, unpublished observa-
tions). It appears that there are subtleties to the reaction
catalyzed by GMD that have yet to be understood. Given
the role of fucose in microbial and human physiology
described above, GMD appears to be a suitable target for
antimicrobial agents as well as for drugs that have anti-
inflammatory or anti-metastatic activities through antago-
nizing selectin-mediated cell adhesion. 
Recently, we and others have determined the structure of
GFS from E. coli [22,23]. This structure establishes GFS as
a member of the short chain dehydrogenase/reductase
(SDR) family, most closely related to UDP-galactose
4-epimerase (GalE). GalE catalyzes the reversible epimer-
ization of UDP-galactose to UDP-glucose and is well char-
acterized both structurally and mechanistically [24–26].
E. coli GMD is also closely related to GalE, sharing 24%
sequence identity at the amino acid level, the same degree
of homology that GMD shares with GFS. The similarities
between GMD and GalE also extend to their reaction
mechanisms. In the case of GalE, a tightly bound NAD is
transiently reduced and then oxidized during the catalytic
cycle; this is a role played by NADP in GMD. Addition-
ally, as with GMD, the hydride that is removed from the
galactose ring by GalE is returned to the same sugar in an
intramolecular hydride transfer. The difference between
the two mechanisms is that the hydride removed from the
C4 of galactose by GalE is returned to the C4, after a rota-
tion of the sugar, to effect an epimerization. In contrast, the
hydride removed from the C4 of mannose by GMD is
returned to the C6, completing a dehydration reaction.
Given the sequence similarity between GMD, GFS, and
GalE, along with the conservation of residues involved in
catalysis and similarities in reaction mechanisms, we pre-
dicted that GMD should have a structure similar to that of
the other two enzymes [22]. 
Here we report the X-ray crystal structure of E. coli GDP-
mannose 4,6 dehydratase, along with the characterization
of cofactor and substrate binding and inhibition by GDP-
fucose. We have built a model of NADP and GDP-
mannose binding to GMD and used this model to identify
several key residues involved in catalysis. Next we con-
firmed their involvement using site-directed mutagenesis.
Results and discussion
Characterization of NADP, NADPH, and GDP-mannose
binding 
Gel filtration chromatography and equilibrium ultracen-
trifugation experiments show that GMD exists as a dimer
in solution (data not shown). These results are consistent
with the crystal structure described below. Both the related
enzymes, GFS and GalE, are also dimers and each binds
two molecules of nicotinamide cofactor and two molecules
of sugar nucleotide per dimer. Both enzymes, therefore,
have the potential for two catalytically active sites per
dimer. To see whether a similar situation exists for GMD
we characterized its substrate and cofactor binding. We
determined the dissociation constant (Kd) for NADP by
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Figure 1
GDP-fucose biosynthesis. NADP bound to
GMD is reduced and then oxidized during the
course of the reaction. GFS catalyzes two
distinct reactions: the epimerization of the
GDP-4-keto, 6-deoxymannose at C3 and C5
followed by the subsequent reduction at C4
to yield GDP-fucose.
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monitoring the decrease in signal intensity at 338 nm
induced by the binding of NADP to the apoenzyme. The
Kd for NADP was determined to be 1.48 ± 0.08 µM with
the data best fitting the Adair–Klotz equation assuming
n = 1 per monomer (Figure 2a). Similarly, the Kd for
NADPH was determined by monitoring the increase in
signal intensity at 445 nm induced by the binding of
NADPH to the apoenzyme. The enzyme showed a
stronger affinity for NADPH than NADP and had a Kd of
0.46 ± 0.01 µM with the data best fitting the Adair–Klotz
equation assuming one NADPH molecule bound per
monomer (Figure 2b). These results indicate that the
enzyme binds one cofactor molecule per subunit, as is seen
for the related enzymes GalE and GFS. GMD shows a
tighter affinity for NADPH than NADP, which is consis-
tent with the enzyme’s demonstrated intramolecular
hydride transfer from the C4 carbon on the mannose ring
to the C6 carbon [14]. To accomplish this, GMD must bind
the GDP-sugar intermediate and the transiently reduced
NADPH tightly so neither can dissociate during the cat-
alytic cycle. Similarly, CDP-glucose 4,6 dehydratase, a
related sugar nucleotide 4,6 dehydratase, binds its reduced
cofactor more tightly than it binds the oxidized form and
carries out intramolecular hydride transfer [27]. The affin-
ity of the apoenzyme for GDP-mannose was also deter-
mined by monitoring the quenching of enzyme
fluorescence upon substrate binding at 338 nm. The Kd
was determined to be 39 ± 2.8 µM, with the data best
fitting the Adair–Klotz equation assuming n = 1 per
monomer (Figure 2c). Thus, as is the case for NADP and
NADPH, the enzyme has two substrate-binding sites for
the substrate GDP-mannose per functional dimer and can,
therefore, be presumed to have two catalytically compe-
tent active sites in its dimeric, biologically active form. 
Steady-state kinetic parameters and inhibition by 
GDP-fucose
It has been known since the 1960s that GDP-fucose is a
feedback inhibitor of GMD activity [16]. To better under-
stand the mechanism of this inhibition and to relate it to
the structure of GMD, we characterized the steady-state
kinetics of GMD and its inhibition by GDP-fucose. We
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Figure 2
Cofactor binding, substrate binding, and
steady state kinetic analysis of GMD.
(a) Determination of Kd for NADP by
quenching of GMD fluorescence. Plot of
fluorescence intensity against total NADP
concentration. Insert shows plot of fraction
bound (ν) against free NADP concentration,
as defined in the Material and methods
section. The data of the insert is fit to the
Adair–Klotz equation. (b) Determination of Kd
for NADPH by increase of GMD
fluorescence. (c) Determination of Kd for
GDP-mannose by quenching of GMD
fluorescence. (d) Analysis of steady-state
kinetics of GMD showing competitive
inhibition by GDP-fucose. Double reciprocal
plots of initial rate data are shown. Each line
represent a fixed GDP-fucose concentration:
circles 0 µM, squares 50 µM, triangles
100 µM, and inverted triangles 200 µM.
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determined the steady-state kinetic values of kcat and KM
for NADP and GDP-mannose using initial velocity studies
that monitored the formation of GDP 4-keto-6-deoxyman-
nose at varying concentrations of GDP-mannose and
NADP (Table 1). Subsequently, we investigated the inhi-
bition of GMD by GDP-fucose. GDP-L-β-fucose was
varied at different concentrations of GDP-mannose, at a
fixed concentration of NADP, and initial rates were deter-
mined. A double reciprocal plot of the initial rate data
shows the lines intersecting on the 1/v axis, indicating that
GDP-fucose is a competitive inhibitor with respect to
GDP-mannose (Figure 2d). The Ki for GDP-fucose
(78.9 ± 10.1 µM) is only twofold greater than the Kd for
GDP-mannose (39.8 ± 2.8 µM), indicating that the
enzyme has evolved to bind both with similar affinities.
The competitive nature of the inhibition indicates that
GDP-fucose binds at the same site on the enzyme that
binds GDP-mannose. This provides a structural rational-
ization for how GDP-fucose, the eventual end product of
the biosynthetic pathway, regulates GMD activity and, in
course, its own biosynthesis.
The tertiary and quaternary structure of GMD
The structure of GMD was solved using the method of
single isomorphous replacement with anomalous scattering
(SIRAS), followed by density modification. The experi-
mental electron-density map that was used to build the
GMD model was of high quality with very few breaks in
the mainchain density and with sidechain electron density
that was clear enough to unambiguously determine the
sequence register. There were three regions of the struc-
ture for which there was no corresponding electron density.
These missing regions consisted of residues 35–55,
313–318, and the last 15 residues at the C terminus of the
enzyme. The GMD model was refined using data between
20.0 Å and 2.3 Å resolution (|F| > 0.0σ) to an R factor of
20.5% (Rfree = 23.2%), with good stereochemistry. 
The GMD monomer is composed of two domains
(Figure 3a). The larger domain containing the N terminus
binds the NADP(H) cofactor. As with many NAD(P)-
binding proteins, this domain forms a Rossmann fold
(reviewed in [28]), consisting of a seven-stranded parallel
β sheet interwoven by seven α helices. The sheet sepa-
rates two groups of helices. One group is made up of
helices B–E, although helices C and D could be viewed as
a single helix with a kink near residue 108. The second
group of helices is made up of a cluster of two helices (A
and G), and by a third helix (helix I) that is spatially sepa-
rated from the first two by a strand. The slightly smaller
C-terminal domain is important in binding the sugar-
nucleotide substrate. This domain is formed predomi-
nantly by a four-strand sheet that cups a cluster of three
parallel helices (helices F, H and J). The two domains
come together to form a deep groove in the enzyme. It is
at this domain interface that the cofactor lies, the substrate
binds, and catalysis occurs. 
GMD crystallizes with a monomer in the asymmetric unit
with the GMD dimer being formed by crystallographic
symmetry (Figure 3b). The dimer interface is formed pri-
marily by helix E and the kinked C–D helix, which pack
against their counterparts from the symmetry-related mol-
ecule to form a four-helix bundle. Approximately 1170 Å2
of the surface of each monomer is buried in the dimer
interface. Dimerization through a four-helix bundle is a
common structural theme for SDR enzymes. GalE [29],
GFS [22], and dihydropteridine reductase [30] all form
four-helix bundles at their dimerization interfaces. The
dimeric structure of GMD is in contrast to earlier reports
for the porcine thyroid GMD and E. coli GMD, which sug-
gested that they were hexamers [11,17].
The structure of GMD makes it a member of the SDR
protein family [31,32], closely related to the UDP-galac-
tose 4-epimerase. This is clearly evident when comparing
the overall folds of the two enzymes (Figure 4). It is inter-
esting to note that GMD also shows high structural similar-
ity to GFS [22,23] (Figure 4), the second enzyme involved
in the synthesis of GDP-fucose. This is despite the fact
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Table 1
Steady-state parameters of wild-type and mutants of GDP-mannose dehydratase.
NADP GDP-mannose
KM kcat Kd KM kcat Kd
(µM) (s–1) (µM) (µM) (s–1) (µM)
WT 38 ± 2 5 ± 0.28 1.5 ± 0.1 280 ± 12 5 ± 0.48 39.8 ± 2.8
T→V 26 ± 1 0.0018 ± 0.0002 1.1 ± 0.1 110 ± 9 0.0015 ± 0.0005 44.1 ± 3.4
K→A 75 ± 4 0.0047 ± 0.0004 4.7 ± 0.7 501 ± 19 0.0053 ± 0.0004 58.8 ± 7.7 
Y→F 55 ± 3 0.0014 ± 0.0003 2.5 ± 0.3 1020 ± 16 0.0019 ± 0.0006 73.8 ± 8.7 
E→Q 42 ± 3 0.0022 ± 0.0006 1.2 ± 0.2 450 ± 23 0.0033 ± 0.0005 67.1 ± 3.7
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that these two enzymes catalyze quite different reactions.
The similarity in three-dimensional structure, coupled
with the observation that the genes for these enzymes are
adjacent to each other on the bacterial genome, suggest
that they evolved from a common ancestor.
The structure of the E. coli GMD, along with a sequence
alignment of GMDs from different organisms (Figure 5),
gives us a strong basis for speculating on the structures of
other GMDs. Overall, the sequence conservation among
the GMD family is strong with sequence identities
between pairs of enzymes ranging from 40–99%. Thus, it
seems probable that the structures of these enzymes will
generally be similar, with the exception of the areas of the
C-terminal domain that do not participate in
sugar–nucleotide binding or in catalysis, for example the
end of helix H, through strands 14–17. The residues that
line the catalytic groove spanning both domains are espe-
cially well conserved, as are a number of residues in the
core of the N-terminal domain, which appear to play a role
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Figure 3
Tertiary and quaternary structure of GMD. (a) Stereoview ribbon
representation of the GMD monomer. The N and C termini of the
protein are labeled. The secondary structural elements are labeled
proceeding from the N to C terminus helices with letters and strands
with numbers. The Rossmann fold is shown in yellow and the 
C-terminal domain in blue. (b) Ribbon representation of GMD, as seen
down the twofold axis. One monomer is in green and the other in blue.
The helices comprising the dimer interface, B, C, D, and E, are labeled.
Figure 4
GMD, GFS, and GalE share the same protein
fold. Ribbon representation of GDP-mannose
4,6 dehydratase (GMD), GDP-fucose
synthetase (GFS), and UDP-galactose
4-epimerase (GalE) showing the common
protein fold. The Rossmann fold domains are
shown in yellow and the C-terminal domains
in blue.
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in maintaining the structural integrity of the Rossmann
fold. Overall, these observations suggest that the tertiary
structure of the E. coli enzyme will be seen in the other
members of the GMD family. The quaternary structure of
this family of proteins is also likely to be conserved.
Although the residues involved in the monomer–monomer
interface, helices C–D and E, are not as well conserved as
some other regions of the structure, the substitutions seen
in this region are generally conservative and are likely to be
compatible with dimer formation. 
Modeling cofactor and substrate binding to GMD
All attempts to obtain a structure of GMD complexed
with various combinations of NADP, NADPH, GDP-
mannose and GDP-fucose to date have failed. The close
sequence homology and structural similarity between
GMD and GalE and between GMD and GFS, however,
allowed us to locate reliably the cofactor and sugar-
nucleotide binding sites, and to position molecules within
them. Both GalE and GFS share approximately 24%
sequence identity with GMD, as well as a strong structural
similarity (Figure 4). In addition, GalE is similar to GMD
in that the mechanisms of both enzymes involve transient
reduction and oxidation of the cofactors, which remain
tightly bound during the reaction. Figure 6 shows a super-
position GMD (magenta) and GalE (cyan), along with the
modeled NADP cofactor and GDP-mannose substrate.
Although there are a number of small structural differ-
ences between the catalytic sites of each enzyme, the
binding sites are similar enough to reliably position the
cofactor NADP and the substrate GDP-mannose within
the GMD structure. Based on the model of this binding
site and an examination of the sequence conservation in
this region, it is possible to point out many of the interac-
tions that are probably relevant to NADP(H) and
GDP-mannose binding to GMD (Figure 7).
In our model of GMD, the adenine group lies in a pocket
bounded by helix C, strands 1 and 2, and by a loop that
stretches between strand 3 and helix B. In the apo form of
GMD, the adenine-binding pocket is largely occupied by
Arg34, which would have to move to accommodate the
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Figure 5
Alignment of GMD genes from different
species. The conserved regions of the GMD
peptides from various species are shown. This
alignment was created with the program
ClustalX [51]. To improve the clarity of the
presentation, the non-homologous C termini
of the proteins were removed along with the N
terminal extension found in the eukaryotic
GMDs. Genbank entries having more than
70% identity to another species already in the
alignment were not included. Genus names
are shown next to the amino acid sequences.
Secondary structural elements of the E. coli
GMD are shown above the sequence,
indicated as colored boxes. Helices are
labeled with letters and strands with numbers
as in Figure 3a. Elements comprising the
Rossmann fold are yellow and elements
forming the C-terminal domain are blue.
Asterisks denote the location of amino acids
predicted from the structure to play a key role
in catalysis, Thr133, Glu135, Tyr156 and
Lys160. Genbank accession numbers are
given in parentheses: Escherichia (U38473),
Synechocystis (D90899), Mycobacterium
(Z79701), Caenorhabditis (Z68215), Human
(AF042377), Helicobacter (AE000526),
Rhizobium (AE000064), Caulobacter
(AF062345), Pseudomonas (Q51366),
Aquifex (AE000722), Methanobacterium
(AE000818), Arabidopsis (U81805).
st8201.qxd  02/29/2000  12:04  Page 128
cofactor. This is reminiscent of the structure of the E. coli
GFS, in which Arg36 occupies a position similar to that
occupied by Arg34 of GMD. In the apo form of GFS, the
arginine is disordered but when NADP is bound the argi-
nine reposititions itself to so that its guanidinium group
stacks on the base. It is possible that a similar reorganiza-
tion takes place in GMD with Arg34 moving to stack over
the adenine. In GFS, Arg36 also helps to coordinate the
2′-phosphate of NADP(H). It is possible that Arg34 plays
a similar role in GMD. Arg35 is the first residue in a disor-
dered region of the molecule that extends through residue
56. It seems likely that the conformation of this stretch of
residues in GMD would be at least partially stabilized by
the binding of the cofactor. Another interaction that is
likely to be important over the entire GMD family is that
between Asp64 and the N1 and/or N6 atoms on the
adenine ring. This aspartate is conserved within the GMD
family of enzymes and is seen in other members of the
SDR family. In GalE, for example, Asp58 occupies almost
exactly the same position. The diphosphate that links the
two ribose sugars lies at the N terminus of helix A, and is
probably stabilized by the helix dipole. 
The proposed nicotinic ribose binding site of GMD is par-
tially occluded by residues Gly87, Ala88, and Met89. A
comparison with other NAD(P)-binding enzymes suggests
that this strand would have to move between 1 and 3 Å to
open up the active site. The nicotinic ribose binding site is
formed almost exclusively by highly conserved residues,
including His187, Arg192, Asn186, Glu135, Phe196, Asp14,
Lys161, Tyr157 and Ser90. Tyr157 and Lys161 are part of a
serine, tyrosine, and lysine triad of residues that are con-
served across the SDR enzymes and that play a part in
cofactor binding and in catalysis. In these enzymes, the
tyrosine hydroxyl group can hydrogen bond to one of the
ribose hydroxyls and the amino group of lysine appears to
interact with both the O2′ and O3′ hydroxyls of the ribose.
In the SDR enzymes, the third conserved residue in the
triad is a serine. The structure of the E. coli GMD, however,
shows that this serine is replaced by a Thr133 in GMD. An
examination of the GMD sequences shows that the residue
at this position is either a threonine or a serine (Figure 5).
In our model the GDP-sugar-binding site is formed by
residues from both of the GMD domains, although the
majority of the relevant residues are contributed by the C-
terminal domain. This is especially true of the binding site
for the GDP moiety, which is formed primarily by residues
from helix F, helix H, strand 8, and strand 9, all of which are
part of the C-terminal domain. The residues involved in
this interaction are highly conserved across the GMD
family. The proposed binding mode would generate con-
tacts with Asn186, Val197, Lys200, Asn225, and possibly
with Leu218, Val259, and Tyr311. The sugar-binding site is
formed exclusively of highly conserved residues. Residues
Asn186, Ser134, Glu135, Leu320, and Ser90 appear in our
model to lie close to the sugar, and all are completely con-
served throughout the GMDs shown in Figure 4.
Site-directed mutagenesis of key catalytic residues
The structure of the E. coli GMD apo enzyme together
with our modeling results and data from other SDR
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Figure 6
Superposition of GMD and GalE. Stereoview
of the Cα trace of GMD (magenta)
superimposed on GalE (cyan). The modeled
cofactor and substrate for GMD, NADP and
GDP-mannose, are shown in black as ball-
and-stick representations. NADP extends from
the lower left with the nicotinamide ring in the
center of the protein and GDP-mannose
extends from the upper right with the
mannose ring toward the center of the protein.
The colors of atoms are as follows: nitrogen,
blue; oxygen, red; carbon, green;
phosphorous, yellow.
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enzymes suggested a key catalytic role for the active-site
residues Thr133, Glu135, Tyr157, and Lys161. Compari-
son of the GMD structure to GalE and GFS indicates that
Thr133, Tyr157, and Lys161 comprise the catalytic triad
common to SDR enzymes. To investigate the role of
these residues in catalysis by GMD, each was individually
mutated and the mutant proteins were purified and char-
acterized as for the wild-type enzyme.
Replacement of Thr133 in GMD with a valine reduced the
kcat of the enzyme by over 3000-fold (Table 1). It had a very
modest effect on the binding of the substrate and cofactor as
measured by KM and Kd. These data suggest a critical role
for Thr133 in GMD catalysis, potentially in a proton shuttle
mechanism with Tyr157 as has been suggested for the anal-
ogous residues in GalE [33]. For comparison, the mutation
of the analogous residue in GalE, Ser124 to an alanine,
reduced the kcat for that enzyme by nearly 3000-fold and
reduced the KM for UDP-galactose by greater than fourfold.
The specific activity of the Ser124→Val mutant of GalE
also has significantly reduced activity, being down greater
than 10,000-fold [33]. Although a threonine in the first posi-
tion of the catalytic triad is unusual for SDR enzymes, there
are examples of residues other than serine at this position.
For example, the SDR family member dihydropteridine
reductase has an alanine in place of the serine. In this
enzyme a water molecule plays the role of the serine
hydroxyl in catalysis [34]. Replacement of the alanine with a
serine using site-directed mutagenesis had little effect on
the activity of the enzyme. In an enzyme more closely
related to GMD, the catalytic serine of GalE was replaced
by a threonine using site-directed mutagenesis. The mutant
enzyme had the same KM for the UDP-sugar substrate and
had a kcat reduced by only threefold [33].
The Tyr157 to phenylalanine mutant of GMD showed a
2500-fold reduction in kcat (Table 1), although showing a
very modest change in KM and Kd for binding the GDP-
mannose substrate and NADP cofactor. The analogous
mutation in GalE, Tyr149→Phe, also showed a dramatic
reduction in kcat greater than 10,000-fold, and reduced the
KM for UDP-galactose by approximately ninefold [33]. A
thorough characterization of the Tyr149→Phe mutant of
GalE suggests that the tyrosine of the catalytic triad plays
the major role as the active-site base in catalysis by GalE
[33]. An analogous role for the tyrosine of the catalytic
triad in other SDR enzymes is supported by the structures
of ternary complexes of these enzymes with their sub-
strates and cofactors [35–37]. Such a role in GMD catalysis
is consistent with our mutagenesis data and we propose
that in GMD Tyr157 acts as a general base facilitating
deprotonation of the C4 hydroxyl, formation of the 4-keto
group, and hydride transfer to NADP.
The final member of the catalytic triad in GMD, Lys161,
was mutated to an alanine. Once again the major effect of
this mutation was on kcat with the mutant enzyme showing
a decrease of almost 1,000 in kcat and having a less than
twofold increase in the KM and Kd for GDP-mannose and a
similarly small change in the binding of NADP (Table 1).
For comparison, mutating the analogous residue in GalE,
Lys153, to alanine reduced the kcat by 2000-fold and
increased KM for UDP-galactose fourfold [38]. We propose
that Lys161 plays a similar role to the analogous residues
in GalE and GFS, coordinatating the ribose hydroxyls of
NADP, and helping to lower the pKa of Tyr157.
The GMD reaction mechanism requires at least one
more basic residue in the active site (see below). Based
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Figure 7
A model of the active-site region of GMD with
cofactor and substrate bound. Stereoview of
the active site of GMD with NADP and
GDP-mannose placed in the active site. The
amino acids conserved across GMD species
and implicated in cofactor and substrate
binding, as well as catalysis, are shown in
magenta. NADP is shown in green and
GDP-mannose is shown in orange. The colors
of the atoms are as follows: nitrogen, blue;
oxygen, red; carbon, green; phosphorous,
yellow. The following residues are shown in
Figure 6 but not labeled: Asp14, Ser90,
Ser134, Asn186, and Val197. 
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upon our model and considering the residues conserved
among the GMDs, only Glu135 fulfills the requirement
for a ‘classical’ base that is in proximity to the sugar ring,
so this residue was mutated to glutamine. The major
effect of this mutation was a greater than 1500-fold
reduction in kcat (Table 1). The mutant protein showed a
less than twofold increase in KM and Kd for GDP-
mannose and had KM and Kd values for NADP similar to
those for the wild-type enzyme. The substitution of an
amide group for an acid in the glutamate to glutamine
mutation, suggests that it is the ability of the acidic
group to abstract a proton that has affected catalysis,
supporting its role as a second active-site base in the
GMD catalyzed reaction.
The catalytic mechanism of GMD
The basics of the GMD reaction mechanism have been
established by experiments with the porcine and bacterial
enzymes [14,39]. The dehydratase reaction catalyzed by
GMD occurs by oxidation of the mannose moiety at the
C4 position, followed by reduction of C6 to a methyl
group to give the GDP 4-keto, 6-deoxymannose interme-
diate. NADP remains tightly bound to the enzyme and
transfers a hydride from C4–C6, regenerating itself during
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Figure 8
GMD reaction mechanisms. Proposed
mechanisms for the reaction catalyzed by
GMD. (a) The mechanism involving the 5,6
mannoseen intermediate. Step Ia: NADP
abstracts a hydride from the C4 position of the
mannose ring. During this step Tyr157 plays
the role of active-site base deprotonating the
4-hydroxyl and stabilizing the 4-keto
intermediate, most likely with the assistance of
Thr133. Step IIa: Glu135 functions as a
general base to remove the C5 proton during
the dehydration step leading to formation of
the 5,6 mannoseen intermediate. Step IIIa: The
hydride abstracted from C4 of the mannose
ring in step I is transferred to C6 completing
the reaction. In this last step Glu135 acts as a
general acid to protonate C5. (b) The
mechanism involving the 4,5-enediol
intermediate. Step Ib: Hydride abstraction from
C4 of the mannose ring occurs as shown with
Tyr157 playing the role of active-site base
deprotonating the 4-hydroxyl and stabilizing the
4-keto intermediate. Step IIb: The 4-keto sugar
tautomerizes to the 4,5 enediol/enolate with
Glu135 acting as a general base to remove the
C5 proton. Step IIIb: Hydride transfer to C6 is
concurrent with loss of water and Glu135
reprotonates C5 to complete the reaction.
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the reaction. The proton at C5 is lost to solvent during the
reaction. The GMD catalyzed reaction has been proposed
to proceed through two potential detailed mechanisms,
both supported by the experimental data [14] (Figure 8).
The first proceeds through three steps. In the first step a
basic group on the enzyme abstracts a proton from the C4
hydroxyl group followed by hydride transfer to the nicoti-
namide ring of NADP resulting in oxidation/dehydrogena-
tion of the substrate and formation of NADPH (step I).
This would be followed by abstraction of the proton from
the C5 position by a second base on the enzyme followed
by syn elimination of a water molecule between C5 and C6
to give a keto-5,6 manoseen species (step II). The final
step would involve a hydride transfer from NADPH to
yield GDP-4-keto-6-deoxymannose and regeneration of
NADP, thus completing the catalytic cycle (step III). The
second potential mechanism involves the formation of a
4-enediol/enolate species as an intermediate in the second
step of the reaction (step IIb). In this mechanism, forma-
tion of the 4-keto sugar and hydride transfer resulting in
the formation of NADPH proceeds as above. Step IIb
would involve enolization of the 4-keto group and abstrac-
tion of the proton at C5 of the sugar by the second active
site base. The final step would involve transfer of the
hydride from NADPH to the C6 carbon followed by elimi-
nation of the water molecule at the C6 position.
In both reaction mechanisms described above, two basic
groups on the enzyme can be envisioned to take part in
the reaction: one in proximity to the C4 hydroxyl group
and the other near the H5 and C6 hydroxyl group. As dis-
cussed previously, we propose that Tyr157 acts as a
general base facilitating deprotonation of the C4 hydroxyl,
formation of the 4-keto group, and hydride transfer to
NADP, whereas Thr133 might act as a proton shuttle in
this reaction. Both reaction mechanisms described also
require at least one additional active-site base to abstract
the C5 proton from the 4-keto species generated after step
I. On the basis of our modeling and mutagenesis data, we
propose that Glu135 plays a role in deprotonation/reproto-
nation of C5 during catalysis in both the mechanisms
described above. This is illustrated in Figure 8. Alterna-
tively, water molecules bound in the active site could help
facilitate catalysis. These roles for Thr133, Glu135, and
Tyr157 are all consistent with the mutagenesis data, which
show dramatic effects on kcat and modest, if any, affects on
substrate or cofactor binding as reflected in KM and Kd.
Biological implications
Fucose is widespread in the glycoconjugates of bacteria,
plants and animals, in which it plays diverse roles in mol-
ecular recognition. Defects in GDP-fucose biosynthesis
have been shown to affect nodulation in Azorhizobium,
survival of Helicobacter pylori under acidic conditions,
stem development in Arabidopsis and immune
regulation in humans. GDP-fucose is synthesized from
GDP-mannose by two enzymes, an NADP-dependent
dehydratase and a dual function NADPH-dependent
epimerase/reductase. Here we report the structure and
kinetic characteristics of the first enzyme in GDP-fucose
biosynthesis, GDP-mannose 4,6 dehydratase (GMD)
from Escherichia coli. GMD is a homodimeric protein
and a member of the short-chain family of dehydroge-
nase/reductases (SDR). Each monomer of GMD binds
one cofactor and one substrate molecule, suggesting both
subunits are catalytically competent. Additionally, GDP-
fucose acts as a competitive inhibitor, binding to the same
site on GMD as the substrate GDP-mannose. This pro-
vides a means of regulating GMD activity and the level of
GDP-fucose in the cell. The structure of GMD is closely
related to that of the second enzyme in GDP-fucose
biosynthesis, GDP-fucose synthetase, suggesting they
arose from a common precursor. GMD is unusual
among SDR enzymes in that it has a threonine in place
of the usual serine as part of its catalytic triad. Glu135
also plays a role in catalysis as an active-site base.
Overall, the structure provides a basis for understanding
the catalytic mechanism of this enzyme and its regulation
by GDP-fucose, and should aid in the development of
compounds that inhibit the activity of GMD and there-
fore see utility as anti-inflammatory or anti-microbial
agents.
Materials and methods 
Expression and purification of E. coli GMD
The majority of the E. coli GMD gene was removed from pSEGMD [9]
as the AgeI-Hind III fragment and the 5′ end of the gene was rebuilt
using the following oligonucleotides: 5′-TATGTCAAAAGTCGCTCT-
CATCA-3′ and 5′-CCGGTGATGAGAGCGACTTTTGACA-3′. The
entire gene was reconstructed as a three-way ligation into the NdeI
and Hind III sites of the E. coli expression vector pRSETB (Invitrogen)
to yield pT7GMD. E. coli strain BL21(DE3/pLysS), containing
pT7GMD, was grown in DM4 minimal salts with 0.5% glucose, trace
metals, and supplemented with 100 mg/l ampicillin and 34 mg/l chlo-
ramphenicol at 25°C in a 10 l Biostat C fermenter (B Braun Biotech
International) to an OD600 of 6. At that point IPTG was added to a final
concentration of 0.3 mM and the cells were grown for an additional 4 h
before being harvested using centrifugation. Typically, 5 g of cells were
resuspended in 100 ml of 50 mM Tris pH 8.0, 1 mM MgSO4, 0.1 mM
PMSF, 50 mM NaCl, 1 µg/ml DNase and 1 µg/ml RNase, and lysed
with a French press. EDTA was added to 1 mM and the supernatant
was cleared by centrifugation. The cleared lysate was applied to a
50 ml Heparin Toyopearl column (TosoHass) equilibrated in 20 mM
Tris, pH 8.0, 5 mM β-mercaptoethanol (BME). The flow through from
this column was applied to a 100 ml DEAE-Toyopearl column (Toso-
Hass), equilibrated in 20 mM Tris pH 8.0, 5 mM BME, washed to base-
line and eluted with a 0.0–0.25 M NaCl gradient in the same buffer.
Fractions containing GMD were pooled and applied to a 40 ml
Ni2+-NTA column (Qiagen) equilibrated in 20 mM Tris pH 8.0, 5 mM
BME, washed with 1 M NaCl, and eluted with 20 mM Tris pH 8.0 plus
50 mM imidazole. GMD-enriched fractions were pooled and applied to
a 20 ml ceramic hydroxyappitite column (Biorad) previously equilibrated
in 5 mM sodium phosphate buffer pH 7.7, and 2 mM DTT. The column
was eluted with a sodium phosphate gradient to 0.25 M. Fractions con-
taining GMD were pooled, diluted to 2 mM sodium phosphate and
applied to a 5 ml PEI-Poros column (Perseptive Biosystems, Inc.) equi-
librated in 20 mM Tris pH 8.0 and 2 mM DTT. The column was washed
to baseline and eluted with a NaCl gradient to 1.0 M. Peak fractions
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were pooled, dialyzed, and concentrated to 12 mg/ml in 20 mM Tris
pH 8.0, 100 mM NaCl, 5 mM DTT, 1 mM NADP. 
Preparation of apoenzyme
The apoprotein was prepared using a previously published procedure
for the removal of NAD from dCDP-glucose 4,6 dehydratase [27]. The
purified protein was dialyzed against 2 l of 50 mM potassium phos-
phate pH 8.0 containing 5 mM EDTA and 1 M potassium bromide. The
buffer was changed periodically over a period of two days. The loss of
NADP was monitored by following the decrease in enzyme activity.
After completely removing the NADP, the enzyme was dialyzed against
50 mM potassium phosphate buffer (pH 8.0) containing 5 mM EDTA
for an additional two days to remove all traces of potassium bromide.
Fluorescence spectroscopy
All fluorescence measurements were carried out at 25°C at pH 7.0 on
a Photon Technology International Fluorimeter with 550 nM GMD.
Binding of NADP to GMD was followed by monitoring the quenching
of enzyme fluorescence intensity, with the excitation wavelength set at
290 nm and the emission monitored at 338 nm. The excitation and
emission slits were 3 nm and 9 nm, respectively. The same procedure
was used to determine the affinity of GMD for GDP mannose. The Kd
for NADPH was determined by following the increase in fluorescence
intensity observed on binding of NADPH to the apoenzyme. For these
measurements, the excitation wavelength was set at 350 nm and the
emission was monitored at 445 nm. The quenching of GMD fluores-
cence on binding of GDP-mannose and NADP was analyzed using a
previously published non-linear least squares procedure that fit the
average number of moles (ν) of bound substrate per mole of protein
versus the free ligand [L]f to the Adair–Klotz equation [27]. The value of
ν was calculated using the same procedure using the relationship
ν = n (I–Ia)/(Ih–Ia) where n = number of binding sites, Ia = fluores-
cence of apoenzyme, I = measured fluorescence intensity at a particu-
lar concentration of substrate, Ih = fluorescence of holoenzyme with its
n number of binding sites saturated with substrate. [L]f was determined
by using the relation [L]f = [L]t–n[Et], where Lt and Et represent total
ligand and total enzyme concentration respectively. The increase in flu-
orescence intensity observed on NADPH binding was also analyzed by
the same procedure after correcting for the intrinsic fluorescence of
free NADPH under the same conditions.
Enzyme assays
Typical reaction conditions were 100 mM MOPS pH 7.0, 100 mM
NaCl, 10 mM DTT, 5 mM EDTA at varying concentrations of GDP-
mannose and NADP at 37°C in a final reaction volume of 250 µl.
25 µM 14C labeled GDP-mannose was added to the samples as a
label. GMD was added to a final concentration of 0.1 mg/ml to initiate
the reaction. The reaction was stopped at different time intervals by
heating the tubes at 100°C for 5 min to inactivate the enzyme. The
reactions were monitored by following the formation of the GDP-4-
keto-deoxymannose peak as judged using high-performance liquid
chromatography (HPLC) [9]. Kinetic constants were determined graph-
ically using S/V versus S plots at different concentrations of GDP-
mannose and NADP. To determine the mechanism of inhibition by
GDP-fucose, initial velocities were measured at various concentrations
of GDP-mannose (400, 600, 800, 1000 µM) at several fixed concen-
trations of GDP-fucose (0, 50, 100, 200 µM). 
Crystallization, crystal cryocooling, and heavy-atom soaking
GMD was crystallized using the hanging drop vapor diffusion method.
Hexagonal crystals were grown by equilibrating a 3 µl drop containing
6 mg/ml GMD, 0.4 M NaK tartrate, 50 mM NaCl, 50 mM HEPES
(pH 7.5), 10 mM Tris (pH 8.0) and 1 mM DTT against a reservoir con-
taining 0.8 M NaK tartrate and 100 mM HEPES (pH 7.5). Although
crystals grew at 18°C and 4°C, the 4°C crystals were generally slightly
larger, and were the ones used for the structure determination.
The GMD crystals decayed rapidly in the X-ray beam, so all of the data
collection was done at approximately –180°C. Before cryocooling, the
GMD crystals were stabilized in a solution consisting of 0.8 M Na K tar-
trate, 100 mM HEPES (pH 7.5), 20 mM Tris (pH 8.0) and 100 mM
NaCl. The concentration of glycerol was increased from 0–20% over
the course of 8 h and the crystals were left to soak in the 20% glycerol
solution for at least 24 h. Cryocooling was performed by quickly plung-
ing the crystals into liquid propane. All of the heavy-atom and small mol-
ecule soaking experiments were carried out directly in the 20% glycerol
solution, supplemented with the heavy atom salt or small molecule of
interest. The successful mercury derivative was prepared by soaking a
crystal for 24 h in cryoprotectant that had been supplemented with
0.25 mM p-chloromercuribenzenesulfonic acid (PCMBS).
Data collection and data processing
The diffraction data were collected on a Quantum 4 CCD detector at
Beamline 5.0.2 at the Advanced Light Source in Berkeley, California
(Table 2). All data were processed using the DENZO and
SCALEPACK software packages [40]. The autoindexing routine in
DENZO suggested that the crystals belonged to the primitive hexago-
nal Bravais lattice, and the scaling and inspection for systematic
absences showed that the spacegroup was P6322, with cell parame-
ters of a = b = 149.6 Å, c = 102.6 Å.
SIRAS phasing
The GMD structure was solved using a single PCMBS derivative. The
position of the heavy atom was determined using difference and anom-
alous Pattersons, with the aid of the program RSPS [41]. Initial refine-
ment of the heavy-atom parameters was done using MLPHARE [41].
Further refinement of the heavy-atom parameters and the SIRAS
phasing was done using SHARP [42], and this was followed by solvent
flattening using the program SOLOMON [43]. The phasing statistics
are summarized in Table 2.
Model building and refinement
The GMD model was built into the solvent-flattened SIRAS-phased
experimental electron-density map using the program O [44]. The
experimental map was of sufficient quality to unambiguously trace most
of the GMD structure. There was some ambiguity in the identity of a
few residues, but their identity was confirmed later in the refinement
using simulated annealing omit maps. After the initial tracing, the model
was refined using cycles of simulated annealing refinement using
X-PLOR v3.843 [45], CNS [46] and manual refitting. In the later stages
of refinement, individual isotropic temperature factors were refined, and
water molecules were very conservatively added to the model.
Throughout the refinement, the quality of the model was monitored by
calculating an Rfree based on approximately 10% of the measured
reflections, and by monitoring the stereochemistry using X-PLOR
v3.843 and PROCHECK [47]. Once the refinement had converged,
the model was further evaluated by systematically doing simulated
annealing omit maps for the entire chain (in groups of 20 residues). 
The final model for GMD consists of residues 335 out of 372 residues,
and includes 114 water molecules. The R factor for this model is
20.5%, with an Rfree of 23.2%, for all data (|F| > 0.0σ) between 20.0 Å
and 2.3 Å resolution. The root mean square (rms) deviations from ideal
bond lengths and angles are 0.009 Å and 1.36°, respectively. The
Ramachandran plot shows that 91% of the residues are in the most
favored region, 8% are in the additionally allowed region and 1% are in
the generously allowed or disallowed regions. The statistics for the final
GMD model are summarized in Table 2.
Modeling of NADP and GDP-mannose binding to GMD
The placement of the substrate and cofactor within the GMD structure
was done conservatively through comparisons with the structures of
GFS (PDB accession number 1FXS) and GalE (PDB accessio number
1KVU). GFS and GalE were each overlayed onto the GMD structure
by a least squares superposition of the backbone atoms of helices B
and E (in the N-terminal domain) and F and H (in the C-terminal
domain); this resulted in a backbone rms difference with those residues
in GMD of 0.86 Å for GFS and 1.50 Å for GalE. GDP-mannose was
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assumed to bind to GMD in a fashion similar to UDP-glucose binding
to GalE. GDP-mannose was therefore positioned in the GMD structure
by overlaying it as closely as possible with the sugar nucleotide in the
transformed GalE structure. Similarly, the cofactor NADP was modeled
into the GMD structure by taking the NAD position in the superposed
GalE structure and attaching a phosphate group to the ribose. In
support of our model, the cofactor NADP bound in a very similar
manner in the related GFS structure.
Analysis and presentation of the structure
The comparison of the various structures and the sequence comparisons
were carried out with the program QUANTA (Molecular Simulations,
Inc.). The assignment of the secondary structure of GMD was done using
the method of Kabsch and Sander, as implemented in PROCHECK [47].
DSSP was used for the solvent accessibility calculations. Molscript [48]
and Raster3D [49] were used for the structure figures.
Site-directed mutagenesis
The gene encoding GMD had previously been inserted as a NdeI-Hind
III fragment into pRSETB to yield pT7GMD. Site-directed mutagenesis
was performed using the Overlap Extension polymerase chain reaction
(PCR) [50] using primers 1–10. Primer 1: GGCTTCCGTCTCT-
GAACTGTATGG; Primer 2: CCATACAGTTCAGAGAC GGAAGCC;
Primer 3: CCG-CGATCTCCGTTTGCGGTCGCCAAACTGTACGCC;
Primer 4: GGCGTACAGTTTGGCGACCGCAAACGGAGATCGCGG;
Primer 5: CCGCGATCTCCGTATGCGGTCGCCGCACTGTACGCC;
Primer 6: GGCGTACAGTGCGGCG ACCGCATACGGAGATCG-
CGG; Primer 7: GGCTTCCACCTCTCAACTGTATGGTCTGGTGC-
AGG; Primer 8: CCTGCACCAGACCATACAGTTGAGAGGT-GGA-
AGCC; Primer 9: GGCGCATATGTCAAAAGTCGC; Primer 10:
GGCGAAGCTTCATGACTCCAGCGCGATCGCCAC.
For each mutation (italicised), two PCR reactions utilizing the forward
and reverse mutagenic primers (Primers 1 and 2 for T133V, primers 3
and 4 for Y157F, primers 5 and 6 for K161A and Primers 7 and 8 for
E135Q) were run using either the initiation codon primer (Primer 9) or
termination codon primer (Primer 10). Plasmid DNA (pT7GMD) was
used as a template. The products obtained from the first PCR reactions
were then used as templates in a second PCR reaction to generate
and amplify a 1 kb product that corresponded to the entire GMD gene
with the NdeI and HindIII sites at the 5′ and 3′ end respectively. These
fragments, containing the mutations, were cloned into the NdeI and
HindIII sites of pRSETb and the sequence of the entire gene was con-
firmed by DNA sequence analysis. The resulting plasmids, containing
the single point mutations, were transformed into BL21 (DE3) cells
from Invitrogen and grown in lucia broth media plus 0.1 mg ml–1 ampi-
cillin and 0.034 mg ml–1 chloramphenicol at 25°C. IPTG (0.3 mM) was
added during the log phase of growth to induce expression of GMD.
The cells were then broken and purified using the same procedure as
above for the recombinant wild-type protein. The assays were per-
formed under the same conditions as that for wild-type enzyme.
Accession numbers
Atomic coordinates and structure factors have been deposited with the
Brookhaven Protein Data Bank for immediate release with the entry
code 1DB3.
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